CAR immune cells: design principles, resistance and the next generation – Nature Alert Breaking News - US, 22 Feb 2023 Abramson, J.
CD22-Directed CAR T-cell Therapy Elicits High CR Rates in LBCL After CD19 Relapse OncLive, 17 Feb 2023 CD22-directed CAR T-cell therapy generated high complete response (CR) rates and manageable safety in heavily…